Global Medical Exoskeleton Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Medical Exoskeleton Market is presumed to reach the market size of nearly USD 9952.24 Billion by 2032 from USD 372.42 Billion in 2023 with a CAGR of 44.06% under the study period 2024-2032.

Medical exoskeletons are wearable robotic devices designed to assist individuals with mobility impairments or disabilities, enabling them to stand, walk, or perform other activities of daily living. These devices provide external support and assistance to the user's musculoskeletal system, augmenting their strength and mobility. It typically consist of lightweight, adjustable frames worn over the user's limbs or torso, along with motors, sensors, and control systems that detect and respond to the user's movements. They are used in rehabilitation settings to help individuals recover from injuries or neurological conditions, such as spinal cord injury, stroke, or multiple sclerosis, by providing targeted physical therapy and gait training.

MARKET DYNAMICS

The medical exoskeleton industry is witnessing significant growth driven by the increasing prevalence of neurological disorders and spinal cord injuries, which necessitate advanced rehabilitation solutions. These devices offer enhanced mobility and independence to individuals with these conditions, significantly improving their quality of life. Technological advancements in robotics and wearable devices have led to the development of more efficient, lightweight, and user-friendly exoskeletons, making them more accessible to a broader patient base. Additionally, the aging global population is contributing to the demand for these devices as elderly individuals seek assistance with mobility and daily activities. The growing awareness and acceptance among healthcare professionals and patients alike are also propelling the industry forward.

Furthermore, substantial investments in research and development are driving innovation, resulting in more effective and affordable solutions. Healthcare facilities are increasingly incorporating exoskeletons into their rehabilitation programs to enhance patient outcomes and reduce recovery times. Regulatory approvals and positive clinical trial results are further validating the efficacy and safety of these devices, boosting their adoption. Government initiatives and funding to support the development and deployment of advanced medical devices are also playing a crucial role in the industry's growth. As the technology continues to evolve and the benefits become more widely recognized, the industry is poised for sustained expansion, offering transformative solutions for mobility impairments. However, high costs and limited accessibility may hinder the medical exoskeleton market growth in the next few years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain Analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Medical Exoskeleton. The growth and trends of Medical Exoskeleton industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Medical Exoskeleton market report provides detailed data on the segments at the country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Component

Hardware
Software

By Type

Powered
Passive

By Extremity

Upper
Lower
Full Body

By Mobility

Mobile
Stationary

By Structure

Rigid
Soft

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Medical Exoskeleton market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Medical Exoskeleton market include Ekso Bionics (US), ReWalk (Israel), Parker Hannifin (US), Cyberdyne (Japan) And Bionik (Canada), Rex Bionics (UK), B-TEMIA Inc. (Canada), Bioventus (North Carolina), Hocoma AG (A Subsidiary Of DIH Technologies) (Switzerland), Wearable Robotics SRL (Italy), Gogoa Mobility Robots SL (Spain), ExoAtlet (Luxembourg), Meditouch (Israel), Suit X (US), P&S Mechanics (South Korea), Marsi Bionics (Spain), Rehab Robotics (Hong Kong), Myomo (US). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11213401

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. MEDICAL EXOSKELETON - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Component
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Extremity
- 3.7.4 Market Attractiveness Analysis By Mobility
- 3.7.5 Market Attractiveness Analysis By Structure
- 3.7.6 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL MEDICAL EXOSKELETON MARKET ANALYSIS BY COMPONENT

5.1. Overview By Component
5.2. Historical and Forecast Data
5.3. Analysis By Component
5.4. Hardware Historic and Forecast Sales By Regions
5.5. Software Historic and Forecast Sales By Regions

6. GLOBAL MEDICAL EXOSKELETON MARKET ANALYSIS BY TYPE

6.1. Overview By Type
6.2. Historical and Forecast Data
6.3. Analysis By Type
6.4. Powered Historic and Forecast Sales By Regions
6.5. Passive Historic and Forecast Sales By Regions

7. GLOBAL MEDICAL EXOSKELETON MARKET ANALYSIS BY EXTREMITY

7.1. Overview By Extremity
7.2. Historical and Forecast Data
7.3. Analysis By Extremity
7.4. Upper Historic and Forecast Sales By Regions
7.5. Lower Historic and Forecast Sales By Regions
7.6. Full Body Historic and Forecast Sales By Regions

8. GLOBAL MEDICAL EXOSKELETON MARKET ANALYSIS BY MOBILITY

8.1. Overview By Mobility
8.2. Historical and Forecast Data
8.3. Analysis By Mobility
8.4. Mobile Historic and Forecast Sales By Regions
8.5. Stationary Historic and Forecast Sales By Regions

9. GLOBAL MEDICAL EXOSKELETON MARKET ANALYSIS BY STRUCTURE

9.1. Overview By Structure
9.2. Historical and Forecast Data
9.3. Analysis By Structure
9.4. Rigid Historic and Forecast Sales By Regions
9.5. Soft Historic and Forecast Sales By Regions

10. GLOBAL MEDICAL EXOSKELETON MARKET ANALYSIS BY GEOGRAPHY

10.1. Regional Outlook
10.2. Introduction
10.3. North America Sales Analysis
- 10.3.1 Overview, Historic and Forecast Data Sales Analysis
- 10.3.2 North America By Segment Sales Analysis
- 10.3.3 North America By Country Sales Analysis
- 10.3.4 United States Sales Analysis
- 10.3.5 Canada Sales Analysis
- 10.3.6 Mexico Sales Analysis
10.4. Europe Sales Analysis
- 10.4.1 Overview, Historic and Forecast Data Sales Analysis
- 10.4.2 Europe By Segment Sales Analysis
- 10.4.3 Europe By Country Sales Analysis
- 10.4.4 United Kingdom Sales Analysis
- 10.4.5 France Sales Analysis
- 10.4.6 Germany Sales Analysis
- 10.4.7 Italy Sales Analysis
- 10.4.8 Russia Sales Analysis
- 10.4.9 Rest Of Europe Sales Analysis
10.5. Asia Pacific Sales Analysis
- 10.5.1 Overview, Historic and Forecast Data Sales Analysis
- 10.5.2 Asia Pacific By Segment Sales Analysis
- 10.5.3 Asia Pacific By Country Sales Analysis
- 10.5.4 China Sales Analysis
- 10.5.5 India Sales Analysis
- 10.5.6 Japan Sales Analysis
- 10.5.7 South Korea Sales Analysis
- 10.5.8 Australia Sales Analysis
- 10.5.9 South East Asia Sales Analysis
- 10.5.10 Rest Of Asia Pacific Sales Analysis
10.6. Latin America Sales Analysis
- 10.6.1 Overview, Historic and Forecast Data Sales Analysis
- 10.6.2 Latin America By Segment Sales Analysis
- 10.6.3 Latin America By Country Sales Analysis
- 10.6.4 Brazil Sales Analysis
- 10.6.5 Argentina Sales Analysis
- 10.6.6 Peru Sales Analysis
- 10.6.7 Chile Sales Analysis
- 10.6.8 Rest of Latin America Sales Analysis
10.7. Middle East & Africa Sales Analysis
- 10.7.1 Overview, Historic and Forecast Data Sales Analysis
- 10.7.2 Middle East & Africa By Segment Sales Analysis
- 10.7.3 Middle East & Africa By Country Sales Analysis
- 10.7.4 Saudi Arabia Sales Analysis
- 10.7.5 UAE Sales Analysis
- 10.7.6 Israel Sales Analysis
- 10.7.7 South Africa Sales Analysis
- 10.7.8 Rest Of Middle East And Africa Sales Analysis

11. COMPETITIVE LANDSCAPE OF THE MEDICAL EXOSKELETON COMPANIES

11.1. Medical Exoskeleton Market Competition
11.2. Partnership/Collaboration/Agreement
11.3. Merger And Acquisitions
11.4. New Product Launch
11.5. Other Developments

12. COMPANY PROFILES OF MEDICAL EXOSKELETON INDUSTRY

12.1. Top Companies Market Share Analysis
12.2. Market Concentration Rate
12.3. Ekso Bionics (US)
- 12.3.1 Company Overview
- 12.3.2 Company Revenue
- 12.3.3 Products
- 12.3.4 Recent Developments
12.4. ReWalk (Israel)
- 12.4.1 Company Overview
- 12.4.2 Company Revenue
- 12.4.3 Products
- 12.4.4 Recent Developments
12.5. Parker Hannifin (US)
- 12.5.1 Company Overview
- 12.5.2 Company Revenue
- 12.5.3 Products
- 12.5.4 Recent Developments
12.6. Cyberdyne (Japan) And Bionik (Canada)
- 12.6.1 Company Overview
- 12.6.2 Company Revenue
- 12.6.3 Products
- 12.6.4 Recent Developments
12.7. Rex Bionics (UK)
- 12.7.1 Company Overview
- 12.7.2 Company Revenue
- 12.7.3 Products
- 12.7.4 Recent Developments
12.8. B-TEMIA Inc. (Canada)
- 12.8.1 Company Overview
- 12.8.2 Company Revenue
- 12.8.3 Products
- 12.8.4 Recent Developments
12.9. Bioventus (North Carolina)
- 12.9.1 Company Overview
- 12.9.2 Company Revenue
- 12.9.3 Products
- 12.9.4 Recent Developments
12.10. Hocoma AG (A Subsidiary Of DIH Technologies) (Switzerland)
- 12.10.1 Company Overview
- 12.10.2 Company Revenue
- 12.10.3 Products
- 12.10.4 Recent Developments
12.11. Wearable Robotics SRL (Italy)
- 12.11.1 Company Overview
- 12.11.2 Company Revenue
- 12.11.3 Products
- 12.11.4 Recent Developments
12.12. Gogoa Mobility Robots SL (Spain)
- 12.12.1 Company Overview
- 12.12.2 Company Revenue
- 12.12.3 Products
- 12.12.4 Recent Developments
12.13. ExoAtlet (Luxembourg)
- 12.13.1 Company Overview
- 12.13.2 Company Revenue
- 12.13.3 Products
- 12.13.4 Recent Developments
12.14. Meditouch (Israel)
- 12.14.1 Company Overview
- 12.14.2 Company Revenue
- 12.14.3 Products
- 12.14.4 Recent Developments
12.15. Suit X (US)
- 12.15.1 Company Overview
- 12.15.2 Company Revenue
- 12.15.3 Products
- 12.15.4 Recent Developments
12.16. P&S Mechanics (South Korea)
- 12.16.1 Company Overview
- 12.16.2 Company Revenue
- 12.16.3 Products
- 12.16.4 Recent Developments
12.17. Marsi Bionics (Spain)
- 12.17.1 Company Overview
- 12.17.2 Company Revenue
- 12.17.3 Products
- 12.17.4 Recent Developments
12.18. Rehab Robotics (Hong Kong)
- 12.18.1 Company Overview
- 12.18.2 Company Revenue
- 12.18.3 Products
- 12.18.4 Recent Developments
12.19. Myomo (US)
- 12.19.1 Company Overview
- 12.19.2 Company Revenue
- 12.19.3 Products
- 12.19.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies